Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Muzammil Mushtaq

Showing results (1-10 of 14) with videos related to

Pageof 2
Sort By:
Cleveland Clinic Journal of Medicine|August 3, 2014
Perioperative beta-blockers in noncardiac surgery: the evidence continues to evolveMuzammil Mushtaq, Steven L Cohn
Journal of the American Society of Hypertension : JASH|June 12, 2013
Combination therapy for hypertension 2013: an updateAyesha Salahuddin, Muzammil Mushtaq, Barry J Materson
World Journal of Gastrointestinal Oncology|July 31, 2012
Oxaliplatin induced disseminated intravascular coagulation: A case report and review of literatureShweta Kurian, Jessica Macintyre, Muzammil Mushtaq, et al.
Journal of Cardiovascular Translational Research|October 31, 2014
Rationale and design of the Percutaneous Stem Cell Injection Delivery Effects on Neomyogenesis in Dilated Cardiomyopathy (the POSEIDON-DCM study): a phase I/II, randomized pilot study of the comparative safety and efficacy of transendocardial injection of autologous mesenchymal stem cell vs. allogeneic mesenchymal stem cells in patients with non-ischemic dilated cardiomyopathyMuzammil Mushtaq, Darcy L DiFede, Samuel Golpanian, et al.
Nature Protocols|July 14, 2012
Myocardial infarction and intramyocardial injection models in swineFrederic C McCall, Kartik S Telukuntla, Vasileios Karantalis, et al.
Journal of the American College of Cardiology|October 31, 2015
Synergistic Effects of Combined Cell Therapy for Chronic Ischemic CardiomyopathyVasileios Karantalis, Viky Y Suncion-Loescher, Luiza Bagno, et al.
Circulation Research|February 26, 2014
Autologous mesenchymal stem cells produce concordant improvements in regional function, tissue perfusion, and fibrotic burden when administered to patients undergoing coronary artery bypass grafting: The Prospective Randomized Study of Mesenchymal Stem Cell Therapy in Patients Undergoing Cardiac Surgery (PROMETHEUS) trialVasileios Karantalis, Darcy L DiFede, Gary Gerstenblith, et al.
Journal of the American College of Cardiology|November 18, 2017
A Combination of Allogeneic Stem Cells Promotes Cardiac RegenerationMakoto Natsumeda, Victoria Florea, Angela C Rieger, et al.
Circulation Research|January 23, 2014
Does transendocardial injection of mesenchymal stem cells improve myocardial function locally or globally?: An analysis from the Percutaneous Stem Cell Injection Delivery Effects on Neomyogenesis (POSEIDON) randomized trialViky Y Suncion, Eduard Ghersin, Joel E Fishman, et al.
The Journals of Gerontology. Series A, Biological Sciences and Medical Sciences|April 27, 2017
Allogeneic Human Mesenchymal Stem Cell Infusions for Aging FrailtySamuel Golpanian, Darcy L DiFede, Aisha Khan, et al.
Pageof 2

Showing results (1-10 of 14) with videos related to

Sort By:
Pageof 2
Cleveland Clinic Journal of Medicine|August 3, 2014
Perioperative beta-blockers in noncardiac surgery: the evidence continues to evolveMuzammil Mushtaq, Steven L Cohn
Journal of the American Society of Hypertension : JASH|June 12, 2013
Combination therapy for hypertension 2013: an updateAyesha Salahuddin, Muzammil Mushtaq, Barry J Materson
World Journal of Gastrointestinal Oncology|July 31, 2012
Oxaliplatin induced disseminated intravascular coagulation: A case report and review of literatureShweta Kurian, Jessica Macintyre, Muzammil Mushtaq, et al.
Journal of Cardiovascular Translational Research|October 31, 2014
Rationale and design of the Percutaneous Stem Cell Injection Delivery Effects on Neomyogenesis in Dilated Cardiomyopathy (the POSEIDON-DCM study): a phase I/II, randomized pilot study of the comparative safety and efficacy of transendocardial injection of autologous mesenchymal stem cell vs. allogeneic mesenchymal stem cells in patients with non-ischemic dilated cardiomyopathyMuzammil Mushtaq, Darcy L DiFede, Samuel Golpanian, et al.
Nature Protocols|July 14, 2012
Myocardial infarction and intramyocardial injection models in swineFrederic C McCall, Kartik S Telukuntla, Vasileios Karantalis, et al.
Journal of the American College of Cardiology|October 31, 2015
Synergistic Effects of Combined Cell Therapy for Chronic Ischemic CardiomyopathyVasileios Karantalis, Viky Y Suncion-Loescher, Luiza Bagno, et al.
Circulation Research|February 26, 2014
Autologous mesenchymal stem cells produce concordant improvements in regional function, tissue perfusion, and fibrotic burden when administered to patients undergoing coronary artery bypass grafting: The Prospective Randomized Study of Mesenchymal Stem Cell Therapy in Patients Undergoing Cardiac Surgery (PROMETHEUS) trialVasileios Karantalis, Darcy L DiFede, Gary Gerstenblith, et al.
Journal of the American College of Cardiology|November 18, 2017
A Combination of Allogeneic Stem Cells Promotes Cardiac RegenerationMakoto Natsumeda, Victoria Florea, Angela C Rieger, et al.
Circulation Research|January 23, 2014
Does transendocardial injection of mesenchymal stem cells improve myocardial function locally or globally?: An analysis from the Percutaneous Stem Cell Injection Delivery Effects on Neomyogenesis (POSEIDON) randomized trialViky Y Suncion, Eduard Ghersin, Joel E Fishman, et al.
The Journals of Gerontology. Series A, Biological Sciences and Medical Sciences|April 27, 2017
Allogeneic Human Mesenchymal Stem Cell Infusions for Aging FrailtySamuel Golpanian, Darcy L DiFede, Aisha Khan, et al.
Pageof 2